No effect seen on mean frailty scores over time or rate of change in mean frailty score with supplementation
WEDNESDAY, Sept. 14, 2022 (HealthDay News) — Neither supplementation with vitamin D₃ nor omega-3 affect the rate of frailty change or incidence over time among older adults, according to a study published online Sept. 13 in JAMA Network Open.
Ariela R. Orkaby, M.D., M.P.H., from the Veterans Affairs Boston Healthcare System, and colleagues conducted a 2 x 2 factorial randomized trial to examine the effects of vitamin D₃ and omega-3 supplements on frailty among 25,871 individuals (men aged 50 years and older and women aged 55 years and older) without cancer or cardiovascular disease. Sufficient data to calculate a frailty index were available for 25,057 participants.
The mean frailty score was 0.109, and 12.7 percent of participants were frail. The researchers found that neither vitamin D₃ nor omega-3 supplementation affected mean frailty scores over time (mean difference at year 5: vitamin D₃, −0.0002; omega-3, −0.0001) or the rate of change in mean frailty score. Over time, incident frailty remained similar. Using the frailty physical phenotype, results were similar.
“These results do not support the routine use of either vitamin D₃ or omega-3 fatty acid supplementation for prevention of frailty in healthy, community-dwelling older adults,” the authors write.
Serum 25(OH)D May Serve as Biomarker of Disease Activity in IBD 
Pharmacist-Led Med Review Improves Medication Quality in Older Patients With Cancer 
Lower Vertebral Bone Mineral Density Linked to Cognitive Decline 
Myeloma Risk Modestly Increased in Adults With Incidentally Detected Vertebral Fracture 
Multicomponent Interventions Offer Little Impact on Fall Risk 
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia .jpg)
Mortality Lowest at Hemoglobin Concentrations Above WHO Thresholds 
Socioeconomic Status Linked to Mortality After Acute Hip Fracture Surgery 
